New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of the deadliest of cancers. Gastric cancer remains a formidable adversary, ...
Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
3don MSN
I Was 21 When My Doctors Told Me I Had A Year To Live. What Happened Next Left Them Stunned.
"The prognosis was so poor that the hospital called in grief counsellors to speak with my family and help prepare them." ...
Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy Compared with CRSa, CRS-HIPEC improved ...
A Q&A with Michael Foote, MD, MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM ...
Image Caption: Proteomic alterations in post-NACT OCPM tissues. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the ...
Neoantigen (tumor-specific antigen) mRNA-based vaccines induce progenitor‑exhausted T cells that support anti‑PD‑1 therapy, leading to enhanced antitumor efficacy against gastric cancer, which has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback